cbdMD, Inc. (NYSE:YCBD ) Q1 2025 Earnings Conference Call February 13, 2025 4:20 PM ET Company Participants Brad Whitford - Chief Accounting Officer Ronan Kennedy - Interim Chief Executive Officer and Chief Financial Officer Conference Call Participants Adam Waldo - Lismore Partners, LLC Thomas McGovern - Maxim Group Operator Good afternoon. Welcome to the cbdMD, Inc.'s December 31, 2024, First Fiscal Quarter of 2025 Earnings Call and Update.
Charlotte, North Carolina--(Newsfile Corp. - February 13, 2025) - (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs today announced our financial results for the first quarter of fiscal year ended December 31, 2024. The Company started fiscal 2025 with a historic quarter, achieving sequential revenue growth, positive net income and, although a loss from operations, the first ever quarter of positive non-GAAP Adjusted EBITDA.
Charlotte, North Carolina--(Newsfile Corp. - February 7, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, February 13, 2025, to discuss the company's December 31, 2024 first quarter of fiscal year 2025 financial results and business progress.
Charlotte, North Carolina--(Newsfile Corp. - January 8, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), a leading and highly trusted CBD company known for its flagship brands cbdMD and Paw CBD, as well as its innovative functional mushroom brand ATRx Labs, today announced that the Company has reduced the principal amount outstanding on its Senior Secured Convertible Notes to approximately $56,000 as of January 8, 2025 as certain holders of the notes have converted amounts under the notes. Since the start of the year, the Company has issued an aggregate of 609,717 shares of common stock as a result of conversion requests and the aggregate balances under the notes have been reduced by approximately $309,000 of principal in addition to accrued interest.
Charlotte, North Carolina--(Newsfile Corp. - January 3, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) ,one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated December 31, 2024, notifying the Company that it is no longer in compliance with an additional NYSE American continued listing standard. Specifically, the letter states that the Company is not in compliance with the continued listing standard set forth in Section 1003(a)(i) of the NYSE American Company Guide (the "Company Guide").
Finishes the year with a stronger cash position. Charlotte, North Carolina--(Newsfile Corp. - December 18, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs today announced our financial results for the full fiscal year ended September 30, 2024.
Charlotte, North Carolina--(Newsfile Corp. - December 18, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Wednesday, December 18, 2024, to discuss the company's September 30, 2024 fourth quarter and fiscal year 2024 financial results and business progress.
Charlotte, North Carolina--(Newsfile Corp. - December 17, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), today announced that it has postponed the release of its financial results and conference call related to the fourth quarter and fiscal year ended September 30, 2024, which had previously been scheduled for December 17, 2024. cbdMD currently expects to issue its fourth quarter and fiscal year 2024 financial results after market close on Wednesday, December 18, 2024.
Charlotte, North Carolina--(Newsfile Corp. - December 12, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, December 17, 2024, to discuss the company's September 30, 2024 fourth quarter and fiscal year 2024 financial results and business progress.
cbdMD Achieves Significant Reduction in Operating Loss as Operational Efficiencies Significantly Improve in Q3 2024 Charlotte, North Carolina--(Newsfile Corp. - August 14, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs today announced our financial results for our third quarter of fiscal 2024 ending June 30, 2024. This quarter, cbdMD made significant strides in its strategic objectives.